Certain patients may derive more benefit from immunotherapy for non-small cell lung cancer - Healio

Men, smokers and younger patients with non-small cell lung cancer all appeared to derive more benefit from immunotherapy, according to a systematic review published in JNCI Cancer Spectrum.Although researchers reported mixed evidence overall, they recommended…

Men, smokers and younger patients with non-small cell lung cancer all appeared to derive more benefit from immunotherapy, according to a systematic review published in JNCI Cancer Spectrum. Although… [+2891 chars]

full article...